LOCUS       UEJ84771                1099 aa            linear   VRL 10-MAR-2022
DEFINITION  surface glycoprotein, partial [Severe acute respiratory syndrome
            coronavirus 2].
ACCESSION   UEJ84771
VERSION     UEJ84771.1
DBSOURCE    accession OL405074.1
KEYWORDS    .
SOURCE      Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
  ORGANISM  Severe acute respiratory syndrome coronavirus 2
            Viruses; Riboviria; Orthornavirae; Pisuviricota; Pisoniviricetes;
            Nidovirales; Cornidovirineae; Coronaviridae; Orthocoronavirinae;
            Betacoronavirus; Sarbecovirus; Betacoronavirus pandemicum.
REFERENCE   1  (residues 1 to 1099)
  AUTHORS   Jary,A., Marot,S., Faycal,A., Leon,S., Sayon,S., Zafilaza,K.,
            Ghidaoui,E., Quoc,S.N., Nemlaghi,S., Choquet,S., Dres,M.,
            Pourcher,V., Calvez,V., Junot,H., Marcelin,A.G. and Soulie,C.
  TITLE     Spike Gene Evolution and Immune Escape Mutations in Patients with
            Mild or Moderate Forms of COVID-19 and Treated with Monoclonal
            Antibodies Therapies
  JOURNAL   Viruses 14 (2), 226 (2022)
   PUBMED   35215820
  REMARK    Publication Status: Online-Only
REFERENCE   2  (residues 1 to 1099)
  AUTHORS   Jary,A., Marot,S., Faycal,A., Leon,S., Sayon,S., Zafilaza,K.,
            Ghidaoui,E., Nguyen Quoc,S., Nemlaghi,S., Choquet,S., Dres,M.,
            Pourcher,V., Calvez,V., Junot,H., Marcelin,A.-G. and Soulie,C.
  TITLE     Direct Submission
  JOURNAL   Submitted (08-NOV-2021) Virology, CHU Pitie Salpetriere Charles
            Foix, 47/83 boulevard de l'hopital, Paris 75013, France
COMMENT     Method: conceptual translation.
FEATURES             Location/Qualifiers
     source          1..1099
                     /organism="Severe acute respiratory syndrome coronavirus
                     2"
                     /isolate="SARS-CoV-2/human/FRA/P10_20210322/2021"
                     /isolation_source="nasopharyngeal swab"
                     /host="Homo sapiens"
                     /db_xref="taxon:2697049"
                     /geo_loc_name="France"
                     /collection_date="2021-03-22"
     Protein         <1..1099
                     /product="surface glycoprotein"
     Region          <1..130
                     /region_name="CoV_Spike_S1_NTD"
                     /note="N-terminal domain of the S1 subunit of coronavirus
                     Spike (S) proteins; cl40465"
                     /db_xref="CDD:477362"
     Region          145..367
                     /region_name="SARS-CoV-2_Spike_S1_RBD"
                     /note="receptor-binding domain of the S1 subunit of severe
                     acute respiratory syndrome coronavirus 2 Spike (S)
                     protein; cd21480"
                     /db_xref="CDD:394827"
     Site            order(145,147,183,207..209,212,216,220,222,239,342..343,
                     347)
                     /site_type="other"
                     /note="trimer interface [polypeptide binding]"
                     /db_xref="CDD:394827"
     Site            order(195..196,198,200,202..204,206,208,210..212,215..216,
                     218,254..256,341,343,345)
                     /site_type="other"
                     /note="cryptic epitope [polypeptide binding]"
                     /db_xref="CDD:394827"
     Site            order(243,272,275,279,281..282,301,312..313,315,319,322,
                     324,326..328,331)
                     /site_type="other"
                     /note="receptor binding site [polypeptide binding]"
                     /db_xref="CDD:394827"
     Site            264..334
                     /site_type="other"
                     /note="receptor binding motif"
                     /db_xref="CDD:394827"
     Region          369..1034
                     /region_name="SARS-CoV-like_Spike_SD1-2_S1-S2_S2"
                     /note="SD-1 and SD-2 subdomains, the S1/S2 cleavage
                     region, and the S2 fusion subunit of the spike (S)
                     glycoprotein from SARS-CoV-2 (COVID-19) and related
                     betacoronaviruses in the B lineage; cd22378"
                     /db_xref="CDD:411965"
     Site            order(429,442,483,535,543,627,900,924,960,984,999,1020)
                     /site_type="other"
                     /note="N-linked glycosylation sites [posttranslational
                     modification]"
                     /db_xref="CDD:411965"
     Site            order(498..502,504,509..514,516..535)
                     /site_type="other"
                     /note="S1/S2 cleavage region"
                     /db_xref="CDD:411965"
     Site            614..632
                     /site_type="other"
                     /note="fusion peptide"
                     /db_xref="CDD:411965"
     Site            642..659
                     /site_type="other"
                     /note="internal fusion peptide"
                     /db_xref="CDD:411965"
     Region          744..809
                     /region_name="heptad repeat 1"
                     /note="heptad repeat 1 [structural motif]"
                     /db_xref="CDD:411965"
     Region          988..1029
                     /region_name="heptad repeat 2"
                     /note="heptad repeat 2 [structural motif]"
                     /db_xref="CDD:411965"
     CDS             1..1099
                     /gene="S"
                     /coded_by="OL405074.1:<1..3302"
                     /codon_start=3
ORIGIN      
        1 flmdlegkqg nfknlrefvf knidgyfkiy skhtpinlvr dlpqgfsale plvdlpigin
       61 itrfqtllal hrsyltpgds ssgwtagaaa yyvgylqprt fllkynengt itdavdcald
      121 plsetkctlk sftvekgiyq tsnfrvqpte sivrfpnitn lcpfgevfna trfasvyawn
      181 rkrisncvad ysvlynsasf stfkcygvsp tklndlcftn vyadsfvirg devrqiapgq
      241 tgkiadynyk lpddftgcvi awnsnnldsk vggnynylyr lfrksnlkpf erdisteiyq
      301 agstpcngve gfncyfplqs ygfqptygvg yqpyrvvvls fellhapatv cgpkkstnlv
      361 knkcvnfnfn gltgtgvlte snkkflpfqq fgrdiddttd avrdpqtlei lditpcsfgg
      421 vsvitpgtnt snqvavlyqg vnctevpvai hadqltptwr vystgsnvfq tragcligae
      481 hvnnsyecdi pigagicasy qtqtnshrra rsvasqsiia ytmslgaens vaysnnsiai
      541 pinftisvtt eilpvsmtkt svdctmyicg dstecsnlll qygsfctqln raltgiaveq
      601 dkntqevfaq vkqiyktppi kdfggfnfsq ilpdpskpsk rsfiedllfn kvtladagfi
      661 kqygdclgdi aardlicaqk fngltvlppl ltdemiaqyt sallagtits gwtfgagaal
      721 qipfamqmay rfngigvtqn vlyenqklia nqfnsaigki qdslsstasa lgklqdvvnq
      781 naqalntlvk qlssnfgais svlndilarl dkveaevqid rlitgrlqsl qtyvtqqlir
      841 aaeirasanl aatkmsecvl gqskrvdfcg kgyhlmsfpq saphgvvflh vtyvpaqekn
      901 fttapaichd gkahfpregv fvsngthwfv tqrnfyepqi itthntfvsg ncdvvigivn
      961 ntvydplqpe ldsfkeeldk yfknhtspdv dlgdisgina svvniqkeid rlnevaknln
     1021 eslidlqelg kyeqyikwpw yiwlgfiagl iaivmvtiml ccmtsccscl kgccscgscc
     1081 kfdeddsepv lkgvklhyt
//

